secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0000064803-23-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q4 revenue $83.8B, adjusted EPS $1.99; guides FY23 adj EPS $8.70-$8.90
--------------------------------------------------------------------------------

- Q4 revenue $83.8B (+9.5% YoY); GAAP diluted EPS $1.75 vs $0.98; adjusted EPS $1.99.
- FY2022 revenue $322.5B (+10.4%); GAAP diluted EPS $3.14; adjusted EPS $8.69.
- FY2023 guidance: GAAP EPS $7.73-$7.93, adjusted EPS $8.70-$8.90, cash flow $12.5B-$13.5B.
- Quarterly dividend increased 10% effective Feb 1, 2023; new $10B share repurchase program authorized.
- Agreement to acquire Signify Health, a leader in home health risk assessments and value-based care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000008/0000064803-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000008/cvs-20230208.htm
  HTML page:      https://secwatch.observer/filing/0000064803-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer